Related Experiment Video
Updated: Jun 10, 2026

20:28
A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments
Published on: October 2, 2012
Pathway engineering results the altered polyhydroxyalkanoates composition in recombinant Escherichia coli
Qiang Li1, Quan Chen, Ming-Ji Li
1State Key Laboratory of Microbial Technology, Shandong University, Jinan, China.
New Biotechnology
|August 24, 2010
Summary
Engineered E. coli DH5α efficiently produces short-chain-length-medium-chain-length polyhydroxyalkanoates (SCL-MCL PHAs) copolymers from mixed sugars and fatty acids. Modulating carbon sources and metabolic pathways controls PHA monomer composition.
Area of Science:
- Biotechnology
- Metabolic Engineering
- Polymer Science
Background:
- Polyhydroxyalkanoates (PHAs) are biodegradable polyesters with diverse applications.
- Efficient production of SCL-MCL PHAs from mixed substrates remains a challenge.
- Metabolic engineering of Escherichia coli offers a promising platform for PHA synthesis.
Purpose of the Study:
- To engineer a metabolically modified Escherichia coli strain for efficient production of SCL-MCL PHAs copolymers.
- To investigate the utilization of mixed carbon sources (sugars and fatty acids) for PHA synthesis.
- To analyze the impact of genetic modifications and substrate composition on PHA monomer composition.
Main Methods:
- Construction of a fadA gene mutant in a phosphotransferase system (PTS) disrupted E. coli DH5α strain.
- Transformation of the engineered E. coli with plasmids expressing PHA synthase genes (pCJY02, pBHR68, pBHR71).
- Cultivation of recombinant strains in media containing glucose and/or decanoate, followed by PHA analysis.
Main Results:
- The pCJY02-harboring recombinant accumulated SCL-MCL PHAs (3HB, 3HHx, 3HO, 3HD) from decanoate with 1.90 wt% copolymer content.
- When utilizing a decanoate and glucose mixture, the recombinant produced SCL-MCL PHAs with significantly higher content (7.3 wt%) and altered monomer ratios.
- The PHA synthase PhaC2(Ps) enabled the synthesis of PHA copolymers from mixed substrates, with composition modulated by carbon source availability.
Conclusions:
- Engineered E. coli DH5α (ΔptsG, ΔFadA) with pCJY02 can efficiently produce SCL-MCL PHAs copolymers from mixed sugars and fatty acids.
- The low-substrate-specificity PHA synthase PhaC2(Ps) is crucial for synthesizing PHA copolymers from diverse carbon sources.
- Metabolic engineering strategies and control of carbon source composition allow for modulation of PHA monomer composition and properties.
Related Concept Videos
Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
Microbial Bioremediation of Plastics
Polyethylene terephthalate (PET) is a synthetic polymer widely utilized in the packaging industry, particularly for bottles and containers. Due to its chemical stability and durability, PET accumulates in the environment, contributing significantly to plastic pollution. It comprises repeating units of terephthalic acid and ethylene glycol, resulting in a semi-crystalline structure that is resistant to natural degradation processes.A notable breakthrough in plastic biodegradation came with the...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...